{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:41:05Z","timestamp":1788792065116,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,12]]},"DOI":"10.7759\/cureus.12652","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T19:13:39Z","timestamp":1610478819000},"source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of 5-Fluorouracil in the Treatment of Pterygium"],"prefix":"10.7759","author":[{"given":"Sobia U","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanveer","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anum","family":"Badar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maeirah","family":"Shafique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidra","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Aaqil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2013.135","article-title":"Intra-lesional 5 fluorouracil for the management of recurrent pterygium","volume":"27","author":"Said D","year":"2013","unstructured":"Said D, Faraj L, Elalfy M, et al.. Intra-lesional 5 fluorouracil for the management of recurrent pterygium. Eye. 2013, 27:1123-1129. 10.1038\/eye.2013.135","journal-title":"Eye"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1136\/bjo.2007.119842","article-title":"The prevalence, severity and risk factors for pterygium in central Myanmar: the Meiktila Eye study","volume":"92","author":"Durkin SR","year":"2008","unstructured":"Durkin SR, Abhary S, Newland HS, Selva D, Aung T, Casson RJ. The prevalence, severity and risk factors for pterygium in central Myanmar: the Meiktila Eye study. Br J Ophthalmol. 2008, 92:25-29.","journal-title":"Br J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/658648","article-title":"Prevalence and risk factors for pterygium in rural older adults in Shandong Province of China: a cross-sectional study","volume":"2014","author":"Jiao W","year":"2014","unstructured":"Jiao W, Zhou C, Wang T, et al.. Prevalence and risk factors for pterygium in rural older adults in Shandong Province of China: a cross-sectional study. Biomed Res Int. 2014, 2014:658648. 10.1155\/2014\/658648","journal-title":"Biomed Res Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2010.10.037","article-title":"Ophthalmic pterygium: a stem cell disorder with premalignant features","volume":"178","author":"Chui J","year":"2011","unstructured":"Chui J, Coroneo MT, Tat LT, Crouch R, Wakefield D, Di Girolamo N. Ophthalmic pterygium: a stem cell disorder with premalignant features. Am J Pathol. 2011, 178:817-827. 10.1016\/j.ajpath.2010.10.037","journal-title":"Am J Pathol"},{"key":"ref5","article-title":"Rotational flap versus simple conjunctival excision in pterygium treatment","volume":"12","author":"Hameed HT","year":"2009","unstructured":"Hameed HT. Rotational flap versus simple conjunctival excision in pterygium treatment. Kufa Med J. 2009, 12:380-381.","journal-title":"Kufa Med J"},{"key":"ref6","article-title":"Basic and Clinical Science Course: External Disease and Cornea","author":"Sutphin JE","year":"2008","unstructured":"Sutphin JE. Basic and Clinical Science Course: External Disease and Cornea. American Academy of Ophthalmology, San Francisco; 2008."},{"key":"ref7","article-title":"In vitro modulation of interleukin-2-mediated human peripheral mononuclear cell proliferation and antitumor cytotoxicity by 5-fluorouracil","volume":"27","author":"Brazowski E","year":"2007","unstructured":"Brazowski E, Eytan K, Eisenthal A. In vitro modulation of interleukin-2-mediated human peripheral mononuclear cell proliferation and antitumor cytotoxicity by 5-fluorouracil. Anticancer Res. 2007, 27:4135-4141.","journal-title":"Anticancer Res"},{"key":"ref8","article-title":"Comparison of primary versus recurrent pterygium after intralesional 5-fluorouracil","volume":"66","author":"Malik S","year":"2016","unstructured":"Malik S, Khan MS, Basit I. Comparison of primary versus recurrent pterygium after intralesional 5-fluorouracil. JPMA. 2016, 66:559-562.","journal-title":"JPMA"},{"key":"ref9","article-title":"Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas","volume":"14","author":"Kim JC","year":"1995","unstructured":"Kim JC, Tseng SC. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea. 1995, 14:473-484.","journal-title":"Cornea"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjopt.2013.02.001","article-title":"The gene therapy revolution in ophthalmology","volume":"27","author":"Al-Saikhan FI","year":"2013","unstructured":"Al-Saikhan FI. The gene therapy revolution in ophthalmology. Saudi J Ophthalmol. 2013, 27:107-111. 10.1016\/j.sjopt.2013.02.001","journal-title":"Saudi J Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3980\/j.issn.2222-3959.2014.03.31","article-title":"The role of heredity in pterygium development","volume":"7","author":"Anguria P","year":"2014","unstructured":"Anguria P, Kitinya J, Ntuli S, Carmichael T. The role of heredity in pterygium development. Int J Ophthalmol. 2014, 7:563-573. 10.3980\/j.issn.2222-3959.2014.03.31","journal-title":"Int J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/179663a0","article-title":"Fluorinated pyrimidines, a new class of tumour-inhibitory compounds","volume":"179","author":"Heidelberger C","year":"1957","unstructured":"Heidelberger C, Chaudhuri N, Danneberg P, et al.. Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature. 1957, 179:663-666. 10.1038\/179663a0","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.172","article-title":"Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing","volume":"94","author":"Caudle KE","year":"2013","unstructured":"Caudle KE, Thorn CF, Klein TE, Swen JJ, McLeod HL, Diasio RB, Schwab M. Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Clin Pharmacol Therapeut. 2013, 94:640-645. 10.1038\/clpt.2013.172","journal-title":"Clin Pharmacol Therapeut"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.11.72","article-title":"Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity","volume":"12","author":"Amstutz U","year":"2011","unstructured":"Amstutz U, Froehlich TK, Largiad\u00e8r CR. Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity. Pharmacogenomics. 2011, 12:1321-1336. 10.2217\/pgs.11.72","journal-title":"Pharmacogenomics"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley DB","year":"2003","unstructured":"Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003, 3:330-338. 10.1038\/nrc1074","journal-title":"Nat Rev Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(98)95034-5","article-title":"Intraoperative mitomycin C to prevent recurrence of pterygium after excision: a 30-month follow-up study","volume":"105","author":"Lam DS","year":"1998","unstructured":"Lam DS, Wong AK, Fan DS, Chew S, Kwok PSK, Tso MOM. Intraoperative mitomycin C to prevent recurrence of pterygium after excision: a 30-month follow-up study. Ophthalmology. 1998, 105:901-905. 10.1016\/S0161-6420(98)95034-5","journal-title":"Ophthalmology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.02.026","article-title":"Efficacy of subconjunctival 5-fluorouracil and triamcinolone injection in impending recurrent pterygium","volume":"113","author":"Prabhasawat P","year":"2006","unstructured":"Prabhasawat P, Tesavibul N, Leelapatranura K, Phonjan T. Efficacy of subconjunctival 5-fluorouracil and triamcinolone injection in impending recurrent pterygium. Ophthalmology. 2006, 113:1102-1109. 10.1016\/j.ophtha.2006.02.026","journal-title":"Ophthalmology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-27492009000200007","article-title":"Safety and efficacy of intraoperative 5-fluorouracil infiltration in pterygium treatment","volume":"72","author":"Valezi VG","year":"2009","unstructured":"Valezi VG, Schellini SA, Viveiros MMH, Padovani CR. Safety and efficacy of intraoperative 5-fluorouracil infiltration in pterygium treatment. Arq Bras Oftalmol. 2009, 72:169-173. 10.1590\/S0004-27492009000200007","journal-title":"Arq Bras Oftalmol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/1110-9173.201625","article-title":"Intraoperative infiltration against topical application of 5-fluorouracil in pterygium treatment","volume":"18","author":"Ibrahim BM","year":"2017","unstructured":"Ibrahim BM, Nada WM. Intraoperative infiltration against topical application of 5-fluorouracil in pterygium treatment. Delta J Ophthalmol. 2017, 18:7. 10.4103\/1110-9173.201625","journal-title":"Delta J Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1995.01100110016008","article-title":"Inefficacy of low-dose intraoperative fluorouracil in the treatment of primary pterygium","volume":"113","author":"Maldonado MJ","year":"1995","unstructured":"Maldonado MJ, Cano-Parra J, Navea-Tejerina A, Cisneros AL, Vila E, Menezo JL. Inefficacy of low-dose intraoperative fluorouracil in the treatment of primary pterygium. Arch Ophthalmol. 1995, 113:1356-1357. 10.1001\/archopht.1995.01100110016008","journal-title":"Arch Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.09.049","article-title":"The Singapore 5-Fluorouracil Trabeculectomy Study: effects on intraocular pressure control and disease progression at 3 years","volume":"116","author":"Wong TT","year":"2009","unstructured":"Wong TT, Khaw PT, Aung T, et al.. The Singapore 5-Fluorouracil Trabeculectomy Study: effects on intraocular pressure control and disease progression at 3 years. Ophthalmology. 2009, 116:175-184. 10.1016\/j.ophtha.2008.09.049","journal-title":"Ophthalmology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/44389-efficacy-of-5-fluorouracil-in-the-treatment-of-pterygium","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:28:22Z","timestamp":1707506902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/44389-efficacy-of-5-fluorouracil-in-the-treatment-of-pterygium"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.12652","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,12]]}}}